UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D/A
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 2)
EMERGING VISION, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.01
(Title of Class of Securities)
859727109
(CUSIP Number)
Michael Goodman, as trustee under the Jaclyn Cohen Trust
100 Quentin Roosevelt Blvd., Suite 516
Garden City, New York 11530
(516) 542-6300
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June 5, 2003
April 14, 2003
(Date of Event which Requires Filing Statement on Schedule 13D)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [ X ].
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Michael Goodman, as trustee under the Jaclyn Cohen Trust
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ X ]
(b) [___]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(e) or 2(f) [__]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF 7. SOLE VOTING POWER 4,608,888*
SHARES
BENEFICIALLY 8. SHARED VOTING POWER 0
OWNED BY
EACH 9. SOLE DISPOSITIVE POWER 4,608,888*
REPORTING
PERSON WITH 10. SHARED DISPOSITIVE POWER 0
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,608,888*
--------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [__]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.45%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
OO
--------------------------------------------------------------------------------
* Includes warrants to purchase 2,039,444 shares of the issuer's common stock
which are exercisable within the 60 day period following the date hereof. In
determining the percentage of class represented by the amount in row (11),
2,039,444 shares were added to the total outstanding shares of the issuer's
common stock.
EXPLANATORY NOTE
This amendment to Schedule 13D is being filed to disclose two
transactions in the securities of Emerging Vision, Inc. (the "Company") effected
by the reporting person on June 5, 2003 and April 14, 2003, respectively.
On June 5, 2003, Dr. Robert Cohen, Horizons Investors Corp., Dr. Alan
Cohen and certain members of the Cohen families (the "Offering Group") proposed
to form EVI Acquisition, Inc. (the "Purchaser") to acquire all of the
outstanding capital stock of the Company by merger of the Purchaser into the
Company (the "Merger").
In connection with the Merger, by letter dated June 5, 2003 addressed
to the Company, the Offering Group offered to pay the holders of the Company's
common stock $0.07 in cash for each share of common stock not owned by the
Offering Group. Holders of vested employee options and warrants will be entitled
to receive in cash the difference between the offered price and the exercise
price.
Pursuant to Rule 13d-1(k)(2) of the Securities Exchange Act of 1934
(the "Exchange Act"), future filings required to be made by Michael Goodman, as
trustee under the Jaclyn Cohen Trust, under Section 13(d)(1) of the Exchange Act
will be made in a group joint filing filed under the name of Dr. Robert Cohen.
On April 14, 2003, the reporting person acquired 2,039,444 units in the
Company's shareholders rights offering, each unit consisting of one share of
common stock and one warrant.
ITEM 1. SECURITY AND ISSUER.
The name of the issuer is Emerging Vision, Inc., a New York corporation, which
has its principal executive offices at 100 Quentin Roosevelt Boulevard, Garden
City, New York 11530. This statement relates to the Company's common stock,
$0.01 par value per share.
ITEM 2. IDENTITY AND BACKGROUND.
(a)-(f). MICHAEL GOODMAN, AS TRUSTEE. This Schedule 13D is being filed by
Michael Goodman, as trustee under the Jaclyn Cohen Trust. Michael Goodman is
deemed to be the beneficial owner of the shares held by him as trustee under the
Jaclyn Cohen Trust, which owns 2,569,444 shares of common stock and warrants to
purchase 2,039,444 shares of common stock. Michael Goodman and Jaclyn Cohen are
citizens of the United States of America. Michael Goodman's principal business
address is 100 Quentin Roosevelt Blvd., Suite 516, Garden City, New York 11530.
Michael Goodman's principal occupation is certified public accountant. During
the last five years, neither Michael Goodman nor Jaclyn Cohen has been (A)
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors) or (B) a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding
was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, Federal or
State securities laws or finding any violation with respect to such laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
See Item 4 for information regarding the transaction reported hereunder that
occurred on June 5, 2003. With respect to the transaction reported hereunder
that occurred on April 14, 2003, the reporting person used personal funds to
acquire the units. The purchase price per unit was $0.04.
ITEM 4. PURPOSE OF TRANSACTION.
On June 5, 2003, the Offering Group proposed to form the Purchaser to
acquire all of the outstanding capital stock of the Company through the Merger.
In connection with the Merger, the Offering Group offered to pay the holders of
the Company's common stock $0.07 in cash for each share of common stock not
owned by the Offering Group. Holders of vested employee options and warrants
will be entitled to receive in cash the difference between the offered price and
the exercise price.
The original Schedule 13G relating to this reporting person and
amendment No. 1 thereto were filed under the name Meryl Cohen a/c/f/ Jaclyn
Cohen and Meryl Cohen a/c/f Gabrielle Cohen.
Completion of the Merger shall be conditioned upon, among other things,
the entering into of a mutually acceptable definitive merger agreement,
clearance of filings required by the Securities and Exchange Commission,
favorable determination by a Special Committee of the Board of Directors of the
Company as to the fairness of the Merger, and approval of the transaction by the
holders of the requisite number of shares of the Company's common stock. The
Offering Group owns 59,776,356 shares of the Company, which gives the Offering
Group beneficial ownership of approximately 74.8% of the Company's common stock.
Assuming the exercise of all warrants and options held by the Offering Group,
the Offering Group owns 107,627,720 shares of the Company's common stock or
approximately 84% of the Company's common stock. Accordingly, the Offering Group
has more than the requisite number of votes to approve the Merger. The Offering
Group does not intend to sell its equity interests in the Company to any third
party.
The members of the Offering Group intend to use their own funds to pay
the merger consideration payable in the Merger.
The Offering Group has orally agreed to vote their shares in favor of
the Merger, but no written agreement currently exists.
On April 14, 2003, the reporting person acquired 2,039,444 units in the
Company's shareholders rights offering, each unit consisting of one share of
common stock and one warrant. The reporting person's acquisition of units on
April 14, 2003 as part of the Company's rights offering was unrelated to the
formation of the Offering Group. The April 14, 2003 transaction was for
investment purposes only.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) Amount of Securities Beneficially Owned: 4,608,888
(b) Number of shares as to which such person has:
(i) Sole power to vote or direct vote: 4,608,888
(ii) Shared power to vote or direct vote: 0
(iii) Sole power to dispose of or direct disposition
of shares: 4,608,888
(iv) Shared power to dispose of or direct disposition
of shares: 0
(c) Transactions in securities of the Company within last 60
days: Acquisition of units in Company's shareholders rights offering, each
consisting of one share of common stock and one warrant.
(d) Third party right to receive dividends or proceeds from sale
of securities: None
(e) Date reporting person ceased to be the beneficial owner of
more than five percent of the class of securities: Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
The Offering Group has an oral understanding regarding the voting of
each member's respective shares in favor of the Merger.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: June 11, 2003
/s/ Michael Goodman
---------------------------------
MICHAEL GOODMAN, AS TRUSTEE UNDER
THE JACLYN COHEN TRUST